498 related articles for article (PubMed ID: 22764581)
1. Fluorofenidone inhibits transforming growth factor-beta1-induced cardiac myofibroblast differentiation.
Chen LX; Yang K; Sun M; Chen Q; Wang ZH; Hu GY; Tao LJ
Pharmazie; 2012 May; 67(5):452-6. PubMed ID: 22764581
[TBL] [Abstract][Full Text] [Related]
2. Fluorofenidone attenuates TGF-β1-induced lung fibroblast activation via restoring the expression of caveolin-1.
Liu J; Song C; Xiao Q; Hu G; Tao L; Meng J
Shock; 2015 Feb; 43(2):201-7. PubMed ID: 25394239
[TBL] [Abstract][Full Text] [Related]
3. Fluorofenidone attenuates tubulointerstitial fibrosis by inhibiting TGF-β(1)-induced fibroblast activation.
Yuan Q; Wang R; Peng Y; Fu X; Wang W; Wang L; Zhang F; Peng Z; Ning W; Hu G; Wang Z; Tao L
Am J Nephrol; 2011; 34(2):181-94. PubMed ID: 21791914
[TBL] [Abstract][Full Text] [Related]
4. The antihepatic fibrotic effects of fluorofenidone via MAPK signalling pathways.
Peng Y; Yang H; Zhu T; Zhao M; Deng Y; Liu B; Shen H; Hu G; Wang Z; Tao L
Eur J Clin Invest; 2013 Apr; 43(4):358-68. PubMed ID: 23438945
[TBL] [Abstract][Full Text] [Related]
5. Fluorofenidone affects hepatic stellate cell activation in hepatic fibrosis by targeting the TGF-β1/Smad and MAPK signaling pathways.
Peng Y; Li L; Zhang X; Xie M; Yang C; Tu S; Shen H; Hu G; Tao L; Yang H
Exp Ther Med; 2019 Jul; 18(1):41-48. PubMed ID: 31258636
[TBL] [Abstract][Full Text] [Related]
6. Fluorofenidone attenuates vascular remodeling in hypoxia-induced pulmonary hypertension of rats.
Li XW; Du J; Hu GY; Hu CP; Li D; Li YJ; Li XH
Can J Physiol Pharmacol; 2014 Jan; 92(1):58-69. PubMed ID: 24383874
[TBL] [Abstract][Full Text] [Related]
7. [Transforming growth factor-beta1 induced phenotypic differentiation of human lung fibroblasts through mitogen activated protein kinase-dependent pathway].
Hu YB; Feng DY; Peng JW; Chu L; Lin Z; Zeng QF
Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi; 2005 Apr; 23(2):109-12. PubMed ID: 16105451
[TBL] [Abstract][Full Text] [Related]
8. Fluorofenidone attenuates diabetic nephropathy and kidney fibrosis in db/db mice.
Wang LH; Liu JS; Ning WB; Yuan QJ; Zhang FF; Peng ZZ; Lu MM; Luo RN; Fu X; Hu GY; Wang ZH; Tao LJ
Pharmacology; 2011; 88(1-2):88-99. PubMed ID: 21847000
[TBL] [Abstract][Full Text] [Related]
9. DIM attenuates TGF-β1-induced myofibroblast differentiation in neonatal rat cardiac fibroblasts.
Li J; Zhang W; Jiao R; Yang Z; Yuan Y; Wu Q; Hu Z; Xiang S; Tang Q
Int J Clin Exp Pathol; 2015; 8(5):5121-8. PubMed ID: 26191207
[TBL] [Abstract][Full Text] [Related]
10. Soluble transforming growth factor-beta1 receptor II might inhibit transforming growth factor-beta-induced myofibroblast differentiation and improve ischemic cardiac function after myocardial infarction in rats.
Lian R; Chen Y; Xu Z; Zhang X
Coron Artery Dis; 2010 Sep; 21(6):369-77. PubMed ID: 20613497
[TBL] [Abstract][Full Text] [Related]
11. Sodium tanshinone IIA sulfonate attenuates the transforming growth factor-β1-induced differentiation of atrial fibroblasts into myofibroblasts in vitro.
Yang L; Hu J; Hao HZ; Yin Z; Liu G; Zou XJ
Int J Mol Med; 2015 Apr; 35(4):1026-32. PubMed ID: 25647570
[TBL] [Abstract][Full Text] [Related]
12. JNK and p38 Inhibitors Prevent Transforming Growth Factor-β1-Induced Myofibroblast Transdifferentiation in Human Graves' Orbital Fibroblasts.
Hou TY; Wu SB; Kau HC; Tsai CC
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33799469
[TBL] [Abstract][Full Text] [Related]
13. Ac-SDKP inhibits transforming growth factor-beta1-induced differentiation of human cardiac fibroblasts into myofibroblasts.
Peng H; Carretero OA; Peterson EL; Rhaleb NE
Am J Physiol Heart Circ Physiol; 2010 May; 298(5):H1357-64. PubMed ID: 20154264
[TBL] [Abstract][Full Text] [Related]
14. Fluorofenidone attenuates hepatic fibrosis by suppressing the proliferation and activation of hepatic stellate cells.
Peng Y; Yang H; Wang N; Ouyang Y; Yi Y; Liao L; Shen H; Hu G; Wang Z; Tao L
Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(3):G253-63. PubMed ID: 24337009
[TBL] [Abstract][Full Text] [Related]
15. Inhibitory effects of PPARγ ligands on TGF-β1-induced CTGF expression in cat corneal fibroblasts.
Jeon KI; Phipps RP; Sime PJ; Huxlin KR
Exp Eye Res; 2015 Sep; 138():52-8. PubMed ID: 26142957
[TBL] [Abstract][Full Text] [Related]
16. Role of extracellular signal-regulated kinase, p38 kinase, and activator protein-1 in transforming growth factor-beta1-induced alpha smooth muscle actin expression in human fetal lung fibroblasts in vitro.
Hu Y; Peng J; Feng D; Chu L; Li X; Jin Z; Lin Z; Zeng Q
Lung; 2006; 184(1):33-42. PubMed ID: 16598650
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta1 targets the GSK-3beta/beta-catenin pathway via ERK activation in the transition of human lung fibroblasts into myofibroblasts.
Caraci F; Gili E; Calafiore M; Failla M; La Rosa C; Crimi N; Sortino MA; Nicoletti F; Copani A; Vancheri C
Pharmacol Res; 2008 Apr; 57(4):274-82. PubMed ID: 18346908
[TBL] [Abstract][Full Text] [Related]
18. Fluorofenidone inhibits TGF-beta1 induced CTGF via MAPK pathways in mouse mesangial cells.
Wang L; Hu GY; Shen H; Peng ZZ; Ning WB; Tao LJ
Pharmazie; 2009 Oct; 64(10):680-4. PubMed ID: 19947172
[TBL] [Abstract][Full Text] [Related]
19. Transforming growth Factor-beta1 induces phenotypic modulation of human lung fibroblasts to myofibroblast through a c-Jun-NH2-terminal kinase-dependent pathway.
Hashimoto S; Gon Y; Takeshita I; Matsumoto K; Maruoka S; Horie T
Am J Respir Crit Care Med; 2001 Jan; 163(1):152-7. PubMed ID: 11208641
[TBL] [Abstract][Full Text] [Related]
20. Effect of Pirfenidone on TGF-β1-Induced Myofibroblast Differentiation and Extracellular Matrix Homeostasis of Human Orbital Fibroblasts in Graves' Ophthalmopathy.
Wu SB; Hou TY; Kau HC; Tsai CC
Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
